Close Menu

Over at O'Reilly Radar, Nat Torkington blogs about his view on the economic slump. In short, he's optimistic that the recession will help both science and the open source movement. In good times, he says, companies innovate less and duplicate other efforts more; "this recession will be good for innovation," he writes. As for open source, Torkington says having less money will inevitably drive people to use free software and operating systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.